Energy & Green Renewable Technology Market News

Nucleic acid labelling market analysis to 2021 insights shared in detailed report

Energy Market Research

The Global Nucleic Acid Labelling Market was worth USD 1381.81 million in 2016 and estimated to be growing at a CAGR of 8.65%, to reach USD 2090.27 million by 2021

Nucleic Acid Labelling have many applications in fields of drug discovery and identification of new diseases.Nucleic acids are large complex molecules which carry genetic information. Two major types of nucleic acids are DNA and RNA.

DNA carries forward function of hereditary characteristics to next generation while RNA carries protein synthesis. Nucleic acids are labelled with tags which facilitate the detection and purification process.

There are many methods involving chemicals and enzymes for labelling nucleic acids like corporation of fluorescent tags, radioactive phosphates, and modifications with biotin, which are primarily utilized in biotechnology applications.

The growth of Nucleic Acid Labelling market is attributed to factors like increasing expenditure for health care, increasing funding for R&D in genomics and disease diagnosis, increasing demand for personalized healthcare. However, factors like expensive processing techniques and lack of skilled professionals are likely to obstruct the growth of market.

Request free sample report at…29/request-sample Make an Inquiry about this news

The Global market for Nucleic Acid Labelling is segmented based on Product, Labelling Technique, Application and End-User. Based on Product – Reagents and Kits, Services.

Based on Labelling Technique – PCR, Nick Translation, Random Primer, In-Vitro Transcription, Reverse Transcription. Based on Application – DNA Sequencing, PCR, Fluorescence in Situ Hybridization (FISH), Microarrays, Blotting, In-Situ Hybridization.

Based on End-Users – Diagnostic Centres, Research Centres, Hospitals.

Based on Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place.

Increasing personalized medicines, identifying the genetic modifications and therapeutic areas have enabled North America to dominate the market. Asia Pacific is expected to grow the fastest due to government initiatives to develop healthcare infrastructure and making the products cost efficient and increased R&D expenditure.

DNA sequencing occupies major share in terms of Applications due to its uses in identification of genetic disorders, tumour genetic variations. Reagents and Kits occupy major share among products segment due to their numerous uses in Diagnostic and Research Centres.

Based on End User Research Centres occupy the major share owing to increasing government funding to increase research activity and drug discovery.

Some of the key players dominating this market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!